However, a recent study proposed that BACH2 increases NRF2-dependent antioxidant response genes in mouse models of type 2 diabetes (T2D), preventing beta-cell damage and increasing its function, suggesting that inhibition of BACH2 could be a potential pharmacological intervention in T2D15. The gene discussed is BACH2; the disease is type 2 diabetes mellitus.